Login / Signup

Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.

Monica E PolczCameron SchlegelGretchen C EdwardsFei WangMarcus TanColleen KiernanCarmen C SolórzanoKamran IdreesAlexander ParikhChristina E Bailey
Published in: Annals of surgical oncology (2020)
PTR was associated with improved OS. Further study is needed to understand how clinicians select patients for PTR.
Keyphrases
  • neuroendocrine tumors
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • patient reported